In addition, discontinuation of a concomitantly used cytochrome P450 3A4 inducer may result in an increase in oxycodone plasma concentration
Preliminary studies have hinted that this peptide might possibly mediate an increase in weight, potentially over 14lbs depending on test models
Kojic acid reduces inflammation by suppressing NF-B activity, preventing the production of pro-inflammatory cytokines
The honest framing is to layer primary interventions (fluid, fiber, activity, osmotic laxatives as needed) with a probiotic that has named strains and defensible evidence in adjacent endpoints, while keeping the prescribing clinician in the loop
Cagrilintide comes at appetite from the amylin side, a hormone pathway that the GLP-1 drugs barely touch
Each week, The Regulatory Review publishes a brief overview of a selected regulatory topic and then distills recent research and scholarly writing on that topic.